CAG
44
-2
CFG
60
10
HBAN
50
5
WBA
66
2
WU
12
2
JNJ
51
12
L
49
4
SLG
27
2
UA
39
-6
FLR
48
2
LB
62
2
TSCO
45
-5
DHR
47
-2
VRSN
59
2
VRSK
42
-5
T
33
4
AON
45
7
TRIP
67
7
OMC
37
2
XRX
45
-3
CAG
44
-2
CFG
60
10
HBAN
50
5
WBA
66
2
WU
12
2
JNJ
51
12
L
49
4
SLG
27
2
UA
39
-6
FLR
48
2
LB
62
2
TSCO
45
-5
DHR
47
-2
VRSN
59
2
VRSK
42
-5
T
33
4
AON
45
7
TRIP
67
7
OMC
37
2
XRX
45
-3
Financhill
Back

Triumph Financial Vs. SpringWorks Therapeutics Industry Stock Comparison

Sell
28

TFIN
Triumph Financial

Last Price:
$89.47
Seasonality Move:
2.72%
Sell
9

SWTX
SpringWorks Therapeutics

Last Price:
$34.00
Seasonality Move:
-2.03%
Sell
28
Triumph Financial (TFIN) is a Sell

Is Triumph Financial a Buy, Sell or Hold?

  • The current Triumph Financial [TFIN] share price is $87.25. The Score for TFIN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • TFIN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
9
SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics a Buy, Sell or Hold?

  • The current SpringWorks Therapeutics [SWTX] share price is $32.50. The Score for SWTX is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • SWTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

TFIN Stock Price Chart

What is Triumph Financial's stock price today?

  • The Triumph Financial share price today is $87.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TFIN is experiencing buying pressure, which is a positive indicator for future bullish movement.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

  • The SpringWorks Therapeutics share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing selling pressure, which indicates risk of future bearish movement.

TFIN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.27 Sell
Relative Strength Index (14 RSI): 38.93 Sell
Chaikin Money Flow: 54992 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (87.18 - 98.8) Sell
Bollinger Bands (100): (79.75 - 98.75) Sell

SWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 37.1 Sell
Chaikin Money Flow: -2546118 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.59 - 40.53) Sell
Bollinger Bands (100): (31.91 - 40.11) Sell

TFIN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 86.95 Buy
20-day SMA: 90.75 Sell
50-day SMA: 96.57 Sell
200-day SMA: 83.83 Buy
8-day EMA: 87.21 Buy
20-day EMA: 90.59 Sell
50-day EMA: 92.7 Sell
200-day EMA: 85.4 Buy

SWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.42 Sell
20-day SMA: 37.4 Sell
50-day SMA: 37.33 Sell
200-day SMA: 38.27 Sell
8-day EMA: 37.61 Sell
20-day EMA: 37.86 Sell
50-day EMA: 37.24 Sell
200-day EMA: 37 Sell

Triumph Financial Earnings Growth & TFIN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.97 per share, and an increase next year of $1.22 per share.

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.12 per share, and an increase next year of $1.33 per share.

Triumph Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

SpringWorks Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):